Dachaigh › Leukemia myeloid geur › Virginia › Richmond
Sgrùdaidhean clionaigeach Leukemia myeloid geur ann an Richmond, VA
Tha 12 sgrùdaidhean airson Leukemia myeloid geur a’ lorg phàirtichean aig làraichean ann agus timcheall air Richmond (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
A’ fastadhÌre 2
- VCU Massey Comprehensive Cancer Center, Richmond
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- agus 3 a bharrachd
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
A’ fastadhÌre 3
- Virginia Commonwealth University - Massey Cancer Center, Richmond
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
A’ fastadhÌre 2
- VCU Massey Comprehensive Cancer Center, Richmond
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
A’ fastadhÌre 2
- VCU Massey Comprehensive Cancer Center, Richmond
Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN
A’ fastadhÌre 2
- Virginia Commonwealth University, Richmond
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
A’ fastadhÌre 3
- VCU Massey Comprehensive Cancer Center, Richmond
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
A’ fastadhÌre 1/2
- VCU Massey Comprehensive Cancer Center, Richmond
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
A’ fastadhÌre 3
- Children's Hospital of Richmond at Virginia Commonwealth University, Richmond
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
A’ fastadhSgrùdadh amharc
- Virginia Commonwealth University, Richmond
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
A’ fastadhÌre 4
- Virginia Commonwealth University, Richmond
Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation
A’ fastadhÌre 1
- Virginia Commonwealth University, Richmond
Sgrùdaidhean Leukemia myeloid geur ann am bailtean eile
- Houston, TX85 sgrùdaidhean
- New York City, NY51 sgrùdaidhean
- Boston, MA44 sgrùdaidhean
- Seattle, WA41 sgrùdaidhean
- Baldwin Park, CA40 sgrùdaidhean
- Columbus, OH35 sgrùdaidhean
- Philadelphia, PA34 sgrùdaidhean
- Durham, NC33 sgrùdaidhean
- Atlanta, GA31 sgrùdaidhean
- Tampa, FL29 sgrùdaidhean
- Chicago, IL26 sgrùdaidhean
- Portland, OR25 sgrùdaidhean
Sgrùdaidhean eile ann an Richmond
- Aillse a' bhroilleach26 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag25 sgrùdaidhean
- Aillse Prostata19 sgrùdaidhean
- Fàilligeadh a' Chridhe16 sgrùdaidhean
- Ailseachadh nan Sgamhan14 sgrùdaidhean
- Galarachd Cardiovasculach13 sgrùdaidhean
- Aillse colorectal13 sgrùdaidhean
- Galar Ae Steatotic12 sgrùdaidhean
- Ailse metastatach12 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil12 sgrùdaidhean
- Melanoma11 sgrùdadh
- Obesity11 sgrùdadh
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.